Mary Lake Polan

mary+lake+polan+medium.jpg

Fund(s): FemTech Fund
Location: New York and Texas

Dr. Mary Lake Polan, M.D., Ph.D., M.P.H., FACOG, will be a lead investor in Portfolia’s Femtech Fund. She is a prolific investor in women’s health companies across the US. She is also Managing Director of Golden Seeds, a women’s investing network and fund. Dr. Polan served as Professor and Chair of the Department of Gynecology and Obstetrics (OBGYN) at Stanford University School

of Medicine from 1990 to 2005, and is now Chair Emeritus. She currently serves as Visiting/Adjunct Professor of Department of Gynecology and Obstetrics at Columbia University School of Medicine. She is employed at Clarient, Inc.

Mary specializes in reproductive endocrinology and infertility and hormonal issues related to gynecology patients and menopause. She chairs a Scientific Advisory Board in Women's Health for the Proctor and Gamble Company and several other advisory boards of private life sciences companies, including Director of Fort Dodge Animal Health S.p.A. and EpiEP, Inc; Independent Director of Quidel Corp.; Non-Executive Director at Motif Bio Plc since February 2004; Board of Directors of ChromaVision Medical Systems Inc and American Home Products; Member of Scientific Advisory Board at OBMedical Company since 2016; Member of the Scientific Advisory Board at The Daily Wellness Company and Arbor Vita Corporation; Director of Metra Biosystems, Inc. since August 1992; Member of Advisory Board of Aviana Molecular Technologies, LLC, Nascent Pharmaceuticals, Inc. and Progenesis Technologies LLC; Member of Scientific Advisory Board and Director at NovaTract Surgical Inc; Director of Mira Dx, Inc; Member of Medical/Technical Advisory Board of Privacomp, Inc.; Director of Wyeth LLC since 1995. She served as Member of the Scientific Advisory Board at TetraLogic Pharmaceuticals Corporation and served on the board of Wyeth Pharmaceuticals prior to its acquisition by Pfizer.